All News
Filter News
Found 86 articles
-
Moderna Reports Third Quarter Fiscal Year 2021 Financial Results and Provides Business Updates
11/4/2021
Moderna, Inc. today reported financial results and provided business updates for the third quarter of fiscal year 2021.
-
The Centers for Disease Control and Prevention’s vaccine advisory committee meets today to discuss authorizing the Pfizer-BioNTech vaccine in children aged 5 to 11 years.
-
The FDA informed Moderna that it would need more time to evaluate the company’s Emergency Use Authorization (EUA) submission for its COVID-19 vaccine for adolescents 12 to 17 years of age.
-
The concern relates to the risk of two rare heart inflammation conditions, myocarditis and pericarditis, that have been linked to the Pfizer and Moderna mRNA vaccines.
-
There is — still — plenty of news about COVID-19 and new drugs, therapies and FDA applications. Here’s a look.
-
Statement from the Council of Chief Medical Officers of Health (CCMOH): Update on COVID-19 Vaccines and the Risk of Myocarditis and Pericarditis
10/1/2021
We continue making great progress with COVID-19 vaccination across Canada. More than 80% of the eligible population aged 12 years and older have now been fully vaccinated.
-
The Pfizer-BioNTech booster shot is now authorized for people over 18 and 65 who are immunocompromised, at high risk due to their work or living situation and front-line healthcare workers.
-
Statement from the Chief Public Health Officer of Canada on August 27, 2021
8/27/2021
The COVID-19 pandemic continues to create stress and anxiety for many Canadians, particularly those who do not have ready access to their regular support networks.
-
As many children go back to school, new waves of COVID-19 cases continue to surge. More data keeps coming in on potential vaccine risks and how they measure up against the risk of the disease. Here’s a look.
-
As governments and now even businesses push citizens to get vaccinated against COVID-19, anti-vaxxers are loading up more ammo for their argument with this week's report.
-
Dysfunctional Red Blood Cells in Children Identified as a Potential Root Cause of Lupus
8/11/2021
Pediatric lupus expert Virginia Pascual, MD together with her junior colleague Simone Caielli, PhD and their team at Weill Cornell Medicine in New York identified problems in the red blood cells of children with active Systemic Lupus Erythematosus (SLE) which may hold clues to a root cause of lupus.
-
Moderna Reports Second Quarter Fiscal Year 2021 Financial Results and Provides Business Updates
8/5/2021
Moderna, Inc., a biotechnology company pioneering messenger RNA therapeutics and vaccines, reported financial results and provided business updates for the second quarter of fiscal year 2021.
-
Clinical Catch-Up: July 26-30
8/2/2021
With the Alzheimer’s Association International Conference conference last week, there were plenty of clinical trial news and updates. Here’s a look. -
The United States and other wealthy nations now stand at an important place in their COVID-19 vaccine campaigns. The question largely turns to vaccinating the remainder of the population – namely, those under 12 years.
-
Moderna continues to assess its COVID-19 vaccine in juveniles, the company is expanding the study to include protocols to detect the potential of rare side effects, including heart inflammation.
-
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.
-
Approximately 100 preliminary reports of GBS have been identified out of 12.8 million doses of the J&J vaccine in the U.S., according to the Centers for Disease Control and Prevention.
-
Statement from the Chief Public Health Officer of Canada on July 2, 2021
7/2/2021
The COVID-19 pandemic continues to create stress and anxiety for many Canadians, particularly those who do not have ready access to their regular support networks.
-
Advisory - Health Canada updates Pfizer-BioNTech and Moderna COVID-19 vaccine labels to include information on myocarditis and pericarditis
6/30/2021
Health Canada has updated the product monographs (labels) for the Pfizer-BioNTech and Moderna COVID-19 vaccines to describe very rare reports of myocarditis and pericarditis following vaccination.
-
UPDATED: Likely Link between mRNA Vaccines and Rare Cases of Heart Inflammation, CDC Panel Says
6/23/2021
Concerns over vaccination links to heart inflammation are valid, a U.S. Centers for Disease Control and Prevention advisory committee announced this afternoon.